Microbiological contamination in counterfeit and unapproved drugs

@inproceedings{Pullirsch2013MicrobiologicalCI,
  title={Microbiological contamination in counterfeit and unapproved drugs},
  author={Dieter Pullirsch and Julie Bellemare and Andreas Hackl and Yvon-Louis Trottier and Andreas Mayrhofer and Heidemarie Schindl and Christine Taillon and Christian Gartner and Brigitte Hottowy and Gerhard Beck and Jacques Gagnon},
  booktitle={BMC Pharmacology and Toxicology},
  year={2013}
}
Counterfeit and unapproved medicines are inherently dangerous and can cause patient injury due to ineffectiveness, chemical or biological contamination, or wrong dosage. Growth of the counterfeit medical market in developed countries is mainly attributable to life-style drugs, which are used in the treatment of non-life-threatening and non-painful conditions, such as slimming pills, cosmetic-related pharmaceuticals, and drugs for sexual enhancement. One of the main tasks of health authorities… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Bioburden Control of Non-sterile Drug Substances and Products - Draft

  • U. S. Pharmacopoeial Convention
  • In United States Pharmacopoeia. Rockville: USP 39…
  • 2013
Highly Influential
3 Excerpts

Evaluating FDA Communications to Reduce Counterfeit and Unapproved Drugs in the Clinical Setting

  • C Jung
  • In Risk Communication Advisory Committee Meeting;
  • 2013
1 Excerpt

Pharmacopoeial Convention : Bioburden Control of Nonsterile Drug Substances and ProductsDraft

  • S. U.
  • 2013

Microbiological Examination of nonsterile Products: Acceptance Criteria for pharmaceutical Preparations and Substances for pharmaceutical use

  • U. S. Pharmacopoeial Convention
  • In United States Pharmacopoeia. Rockville…
  • 2012
2 Excerpts

Similar Papers

Loading similar papers…